Characterisation of an IMP-7-producing ST357 Pseudomonas aeruginosa isolate detected in Denmark using whole genome sequencing

Int J Antimicrob Agents. 2015 Feb;45(2):200-1. doi: 10.1016/j.ijantimicag.2014.11.002. Epub 2014 Nov 29.

Authors

Anette M Hammerum¹, Lotte Jakobsen², Frank Hansen², Marc Stegger², Lisbeth Agersnap Sørensen³, Paal S Andersen², Mikala Wang⁴

Affiliations

¹ Department of Microbiology and Infection Control, Statens Serum Institut, Artillerivej 5 (47/212), DK-2300 Copenhagen S, Denmark. Electronic address: ama@ssi.dk.
² Department of Microbiology and Infection Control, Statens Serum Institut, Artillerivej 5 (47/212), DK-2300 Copenhagen S, Denmark.
³ Hammel Neurorehabilitation and Research Centre, Hammel, Denmark.
⁴ Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.

PMID: 25511191
DOI: 10.1016/j.ijantimicag.2014.11.002

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology
Denmark
Genome, Bacterial*
Microbial Sensitivity Tests
Pseudomonas aeruginosa / drug effects
Pseudomonas aeruginosa / genetics
Pseudomonas aeruginosa / metabolism*
beta-Lactamases / biosynthesis*

Substances

Anti-Bacterial Agents
beta-Lactamases
beta-lactamase IMP-7 protein, Pseudomonas aeruginosa